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2ABSTRACT
Objective:
To explore the accuracy of routinely-collected prevention of mother-to-child transmission of HIV 
(PMTCT) coverage data in Kenya. 
Methods:
In case studies at two government hospitals, we reviewed national reporting guidelines, interviewed
nurses, and undertook a retrospective analysis of routine hospital data from antenatal care (ANC), 
maternity and HIV services from January 2009 to June 2010. Each woman attending these services 
was given a unique study number to enable analysis of her recorded use of PMTCT services across 
different hospital visits. These data were compared with the hospitals’ monthly PMTCT reports to 
the district.
Results:
Where a woman made more than one visit, PMTCT drug provision could be reported multiple times 
for the same woman, and women known to be HIV-positive prior to pregnancy were omitted from 
the denominator of PMTCT coverage calculations. Practices for reporting data on maternal PMTCT 
prophylaxis provision varied in the two hospitals.
According to study data, using the hospital registers and accounting for multiple visits by the same 
woman, 642 women were known to have HIV and 412 (64%) were given maternal PMTCT 
prophylaxis. According to the monthly reports, 430 women were diagnosed with HIV in pregnancy-
related services and 538 (125%) were given maternal PMTCT prophylaxis.  
Conclusions:
If replicated elsewhere, these reporting practices could lead to over-estimation of national PMTCT 
coverage. Simple yet accurate routine data collection systems are needed to monitor PMTCT 
coverage accurately and to highlight where changes need to be made so as to ensure that infants are 
born HIV-free.
3BACKGROUND
Interventions for the prevention of mother-to-child transmission of HIV (PMTCT) have been shown 
to be efficacious,[1-3] but will only realise their potential if their coverage is maximised. 
Kenya reported to UNAIDS that 72% of HIV positive pregnant women received antiretrovirals (ARVs) 
for PMTCT in 2009.[4] However, in the same report, 27% of children born to HIV-infected mothers 
were reported to have been HIV-infected,[4] suggesting that effective PMTCT coverage is less 
complete. One explanation could be inaccurate source data. The source of the data reported to 
UNAIDS was not specified and no information was provided on the PMTCT regimen used or the age 
at which the infants’ status was determined. 
Previous studies, primarily in South Africa, have highlighted deficiencies in PMTCT reporting systems 
including the multitude of paper-based registers that constitute the basis for health facility reports 
to the district, data collection instruments not being used as intended, and incomplete reporting.[5-
7] The accuracy of routinely-collected PMTCT data has not been assessed elsewhere in Africa, 
including Kenya. A study of reporting by HIV voluntary counselling and testing centres in Kenya
found substantial discrepancies between data at national-level and the source health facilities .[8]
Recognising the difficulties inherent in measuring PMTCT coverage, the aims of this study were to 
assess the accuracy of health facility reports of PMTCT coverage based on routinely-collected data in 
two government hospitals in Kenya, and to identify reasons for discrepancies in data and where 
changes in routine data collection methods might improve the accuracy of PMTCT coverage 
estimates.
DESIGN AND METHODS
Study setting and sites
4We reviewed the PMTCT reporting system  in Naivasha District, Rift Valley Province, Kenya. There 
were two government hospitals in Naivasha District – Naivasha District Hospital and Gilgil Sub-
District Hospital. Between them, they provided approximately 35% of HIV testing within antenatal 
care (ANC) services in the district. Based on hospital reports to the district health office, for the 
period January – June 2010, HIV prevalence among antenatal women was about 4% in Naivasha and 
6% in Gilgil.
These study facilities constituted a convenience sample of clinics selected as they were government 
hospitals without unusual levels of external involvement in their day-to-day running such as NGO 
activities or large-scale research projects.
Methods
The national reporting guidelines[9] and reporting instructions in hospital registers were reviewed 
and 7/14 nurses responsible for reporting on PMTCT at Naivasha and Gilgil Hospitals were 
interviewed to establish facility-level reporting practices.
A retrospective analysis was carried out of routine hospital registers in ANC, the maternity ward and
the HIV clinic in the study hospitals for the period 1st January 2009 – 30th June 2010. Data on socio-
demographic characteristics and the reported provision of maternal prophylaxis for PMTCT were 
extracted from the registers into Epi-Data and transferred into Stata for analysis. Many women 
appeared several times in these registers reflecting their multiple visits to ANC/maternity/HIV
services. A ‘matching’ algorithm was devised based on ANC/maternity numbers and available 
demographic information (name, age, location of residence and gestational age) to identify and link 
data on repeat-attendees. We gave each individual woman a unique study number to enable 
analysis of her recorded use of services across different hospital visits and clinical departments. 
These data were compared with the hospital’s monthly reports to the district health office. 
5Ethical approval for this work was provided by the University of Nairobi Kenyatta National Hospital 
Ethics Review Committee and the London School of Hygiene & Tropical Medicine Ethics Committee.
To preserve confidentiality, all files and databases were password-protected and, following matching 
and the assignment of unique study numbers, all personal identifiers were removed from active files.
RESULTS
Collation of national-level indicator data
The Kenyan PMTCT coverage rates that form the basis for national-level reporting are collated from 
monthly reports from individual facilities to the district, and thence to the provincial and national 
levels.  Facility-level reporting is paper-based. At the district-level, data are entered into an 
electronic register, enabling computerised aggregation of indicators from facility-level up to district, 
provincial and national-levels to generate coverage estimates.
The national-level indicator is defined by the national PMTCT guidelines as the ‘ratio of known HIV-
infected pregnant women in ANC receiving ARV preventive prophylaxis’, which is calculated by 
dividing ‘the total number of HIV-infected pregnant women in ANC receiving maternal ARV 
prophylaxis’ by ‘the total number of pregnant women who are diagnosed with HIV in the ANC’.[9]
Although at odds with the indicator’s description, only HIV diagnoses made during ANC are included 
in the denominator, thus excluding women known to be living with HIV prior to pregnancy, even 
though they will also require prophylaxis if they are not receiving highly active antiretroviral therapy 
(HAART) for their own health. 
For women not taking HAART, national PMTCT guidelines for maternal prophylaxis during the study 
period recommended zidovudine (AZT) from 28 weeks; single dose nevirapine (sdNVP), lamivudine 
(3TC) and AZT at delivery; and 3TC and AZT for seven days post-partum.[9]
6Instructions for facility-level reporting
Nurses at both study facilities reported that the woman’s HIV status, irrespective of time of 
diagnosis, was recorded in the client-held booklet provided to the woman when she first attended 
ANC, but no record of whether prophylaxis was issued was made in this booklet.
Within the study hospitals, facility-based records in ANC were in the form of paper registers 
designed and supplied by the Kenyan government, with technical support from USAID, that were 
filled in by hand.  At both hospitals, the nurses reported that every time a woman attended ANC, 
data related to that visit, including her HIV status and receipt of maternal prophylaxis, was entered
on a new line in the register. To avoid double-counting of women diagnosed with HIV in ANC and 
delivery services, the nurses reported that they had been instructed to enter ‘Y’ for “Yes” in the ‘HIV 
status’ column only if the client was diagnosed with HIV during that visit. 
The instructions for filling in the maternal prophylaxis column in the official ANC and maternity 
registers were ambiguous in the national guidelines and facility registers: ‘Indicate if client is given 
ARV prophylaxis: record ‘Y’ or ‘N’’.[9] Nurses’ interpretations of these instructions are presented in 
Table 1. There was no data capture system within the clinic registers for the nurses to report which 
drugs had been dispensed.
Every month, reports summarising these data were submitted to the district-level health office on a 
standard form supplied by the Ministry of Medical Services.
Facility-level reporting practices
The methods of reporting on maternal prophylaxis for PMTCT were markedly different in the two 
study hospitals as outlined in Table 1.
7Table 1: Reporting practices on maternal PMTCT prophylaxis by hospital
Naivasha District Hospital Gilgil Sub-District Hospital
Reporting in ANC
Source of maternal prophylaxis sdNVP dispensed in ANC
Referral to HIV clinic for AZT
sdNVP and 1-month AZT supply 
dispensed in ANC
Referral to HIV clinic for 
subsequent antenatal AZT
Register used in ANC for monthly 
reporting
A notebook, filled in by hand and 
kept in the ANC PMTCT room, used 
to list women to whom maternal 
prophylaxis has been dispensed 
Official Ministry of Health ANC 
register
When nurses indicated in the 
register that maternal prophylaxis 
has been given
Every time a woman is dispensed 
sdNVP from ANC
Every time an HIV-positive woman 
attends ANC, whether she has 
been given maternal prophylaxis at 
that visit or reports having been 
given it at a previous visit
How the monthly report was 
compiled
Counting the women appearing in 
the notebook kept in the ANC 
PMTCT room each month
Tallying the ‘Ys’ in each column of 
the register for the month, i.e. all 
visits by all women are captured. 
In the monthly reports it is 
impossible to distinguish between 
one woman who has attended 
ANC the recommended 4 times 
and was given maternal 
prophylaxis once, and 4 women 
who each attended and were given 
maternal prophylaxis once. 
Reporting in the delivery ward
Availability of prophylaxis in the 
delivery ward
Full regimen of sdNVP, AZT and 
3TC available
sdNVP and 24-hour supply of AZT 
and 3TC available in the delivery
ward. Referral to HIV clinic for the 
remaining AZT and 3TC
Register used in delivery ward for 
monthly reporting
A notebook, filled in by hand and 
kept in the maternity PMTCT 
room, was used to list women to 
whom maternal prophylaxis has
been dispensed
Official Ministry of Health 
maternity register
When to indicate in the register 
that maternal prophylaxis has 
been given
If any maternal prophylaxis 
dispensed while at maternity
If any maternal prophylaxis is 
taken by the woman while at 
maternity, irrespective of which 
drug(s) or where it was 
prescribed/dispensed
How the monthly report was 
compiled
Counting the women appearing in 
the notebook kept in the 
maternity PMTCT room each 
month
Tallying the ‘Ys’ in each column of 
the register for the month, i.e. all 
visits by all women are captured so 
if a woman attended the maternity  
ward more than once she would 
be counted more than once.. 
8Despite the variation in the way hospital registers were filled in, nurses reported that this process, 
although time-consuming, was straightforward. However, they also reported that it was time-
consuming and yielded no direct benefit to their own work. Compiling monthly reports to the district 
was reported to be more complicated as it involved collating data from multiple registers. 
Our study was conducted in only two hospitals and therefore provides a limited view of what might 
be happening nationwide. However, discussions with health workers in another district hospital, 
four health centres and one dispensary suggest that their reporting practices were similar to those in 
Gilgil Hospital.
Study data on maternal PMTCT prophylaxis by hospital
After linking any multiple attendances by the same woman, the registers showed that 515 and 127
women of known HIV positive status attended ANC/maternity services during the 18-month study 
period in Naivasha and Gilgil Hospitals, respectively. Many of these women were recorded as having 
received maternal prophylaxis multiple times (Table 2).
9Table 2: Number of times women were recorded as having received maternal prophylaxis in the ANC and 
maternity registers
No. of times the 
woman was
reportedly given 
prophylaxis
according to the 
hospital 
registers1
Data from ANC and maternity registers 
combined (Jan 2009-June 2010)
Naivasha District 
Hospital
Gilgil Sub-District 
Hospital
0 186 36.1% 44 34.6%
1 266 51.7% 63 49.6%
2 56 10.9% 15 11.8%
3 7 1.4% 3 2.4%
4 0 0.0% 2 1.6%
Total 515 127
Key:
1 Due to lack of specificity in the hospital registers, it was unclear which prophylactic drugs were 
given to women. This could range from sdNVP to the full regimen in the national guidelines (i.e. NVP, 
AZT and 3TC). In Naivasha District Hospital, the minimum regimen usually provided was sdNVP; in 
Gilgil Sub-District Hospital, most women were given sdNVP and AZT.
More than one third of women in each hospital were recorded as not having received any maternal 
prophylaxis. Limiting this analysis to women who attended ANC, these proportions remained high at 
31% and 29% in Naivasha and Gilgil Hospitals, respectively.
None of the nurses interviewed had previously perceived any problems with the accuracy of the 
data in hospital registers or monthly reports but when the results of this study were presented to 
them they said they did not believe the high recorded levels of non-provision of prophylaxis and
suggested that they might sometimes fail to record the provision of maternal prophylaxis, despite 
having actually given it to the woman.
10
Table 3 compares the data extracted directly from the registers with the monthly reports submitted 
to the district for each of the study hospitals, and with the best estimate of the correct number 
based on study data. 
Table 3: Data on maternal PMTCT prophylaxis by source (Jan 09 – June 10)
Naivasha District Hospital
ANC Delivery Combined
Registers
Monthly 
report
Best 
estimate 
from 
study1 Registers
Monthly 
report
Best 
estimate 
from 
study1 Registers
Monthly 
report
Best 
estimate 
from 
study1
HIV+ women 196 191 2452 265 89 285 461 280 515
PMTCT ARVs 
dispensed 113 189 121 150 221 208 263 410 329
Coverage3
(%) 58% 99% 49% 57% 248% 73% 57% 146% 64%
Gilgil Sub-District Hospital
ANC Delivery Combined
Registers
Monthly 
report
Best 
estimate 
from 
study1 Registers
Monthly 
report
Best 
estimate 
from 
study1 Registers
Monthly 
report
Best 
estimate 
from
study1
HIV+ 
women2 86 119 95 69 31 32 155 150 127
PMTCT ARVs 
dispensed 77 99 35 41 29 48 118 128 83
Coverage (%) 90% 83% 37% 59% 94% 150% 76% 85% 65%
1 This is based on the study’s ‘matching algorithm’ and accounts for multiple visits to MCH services by the 
same woman.
2 This includes 45 women who appeared in the PMTCT book but not the ANC register.
3 Coverage of greater than 100% suggests that only women newly diagnosed wtih HIV in pregnancy-related 
services were included in the numerator while some women of previously known HIV-positive status who also 
attended and were given maternal prophylaxis were included in the denominator.
There were discrepancies between the number of HIV-positive women, the courses of maternal 
PMTCT prophylaxis dispensed, and the coverage in the monthly reports and the registers from which 
they were compiled. Because recording of HIV-positive women in ANC/maternity registers was 
limited to newly-diagnosed women, it was impossible to ascertain the total number of HIV-positive
pregnant women (including those of previously-known status) who would therefore benefit from 
either prophylactic ARVs or HAART.  This was particularly evident in the reporting by the maternity 
departments where the number of women given maternal prophylaxis exceeded the number of 
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women diagnosed with HIV, suggesting coverage of more than 100%. Although some of the women 
in the maternity ward attended ANC in the same hospital, many women delivered in these hospitals 
having been diagnosed with HIV during ANC in a different facility; they were therefore not included 
in the denominator of coverage estimates but they were included in the numerator.  
After accounting for multiple visits to MCH services by the same woman in the registers, the best 
estimate from the study found PMTCT coverage of 64% and 65% in Naivasha and Gilgil Hospitals, 
respectively, while the monthly reports showed coverage of 146% and 85%, respectively. 
Uptake of maternal PMTCT prophylaxis in the HIV clinic
Using the study’s matching algorithm, inspection of the HIV clinic registers showed that only 26/245 
(11%) and 11/95 (12%) women diagnosed with HIV in ANC in Naivasha and Gilgil Hospitals, 
respectively, were recorded as having been given AZT monotherapy by the HIV clinic (presumably 
antenatally, otherwise 3TC should also have been prescribed). In addition, only 6/285 (2%) women
discharged from maternity in Gilgil Hospital passed through the HIV clinic, suggesting that 
incomplete prescription of post-partum prophylaxis was common. Conversely, twelve women (5%) 
in Naivasha Hospital and six women (6%) in Gilgil Hospital who were recorded in the ANC registers as 
not having been given any maternal prophylaxis had either received AZT or initiated HAART during 
that pregnancy according to the HIV clinic records. 
DISCUSSION
As has been found elsewhere,[6, 10] it was remarkably difficult to calculate the true coverage of 
PMTCT services using routine data in the study hospitals. In this study, this was primarily because
some women were included in the numerator for these calculations (if they were given maternal 
PMTCT prophylaxis) but not necessarily in the denominator (if they were of previously-known HIV-
12
positive status). As a result of the different reporting methods adopted, each study hospital reported 
different data under the same indicator, which were then collated at district- and national-levels.
Across both hospitals, over one-third of HIV-positive women appear, from direct study of the clinic 
registers, not to have received any maternal prophylaxis for PMTCT during the 18-month study 
period, which is of concern. This was not apparent from the hospitals’ reported data as both 
reported very high PMTCT coverage - 146% in Naivasha Hospital and 85% in Gilgil Hospital. 
Data from an evaluation of the national PMTCT programme in Kenya in 2010 reported that coverage 
of maternal ARV prophylaxis was 79% and of infant prophylaxis was 63% while the rate of vertical 
HIV transmission among infants over 6 weeks of age was reported to be 8%.[12] This was a mixed-
methods cross-sectional study, carried out in 325 health facilities nationwide, based on focus group 
discussions and administration of questionnaires to women bringing their infants to child health 
services. Its findings are a closer reflection of this study’s findings than any of the routinely collected 
data reviewed. Studies such as these contribute to a better understanding of national-level coverage 
of services but are expensive to conduct and ways need to be found to ensure routine data 
accurately reflect PMTCT coverage. 
Although as yet unpublished, further data suggest that problems in the reporting of PMTCT coverage 
may be occurring elsewhere in Kenya. Routinely-collected PMTCT coverage data from three of the 
largest PMTCT programmes in the country were reported at a recent meeting showing that 2,023 
women were expected to need maternal PMTCT prophylaxis, and 4,309 (213%) were given these 
drugs. (Yonga, I. Pers. comm. 2011.) It is likely that the double-counting of maternal PMTCT 
prophylaxis provision that we found in our study also occurred in these programmes, leading to 
over-estimation of coverage. We are not aware of any published studies that directly addressed the 
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reporting issues we studied but suggest that sufficient data now exist in both this study and the 
unpublished studies mentioned above to warrant further attention to PMTCT reporting in Kenya.
Similar to findings from a study in South Africa,[6] daily recording of maternal prophylaxis dispensed 
in ANC in Naivasha Hospital was fairly accurate but the monthly reports did not reflect the daily 
records. The practice in Gilgil Hospital of recording ‘Y’ in the maternal prophylaxis column every time 
a woman received, or was assumed to have received, any prophylaxis and tallying these ‘Ys’ for the 
monthly report led to substantial over-estimation of the number of women receiving maternal 
antiretroviral prophylaxis for PMTCT due to women making repeat visits being counted multiple 
times. 
Data from the HIV clinic revealed that a very low proportion of eligible women accessed AZT there 
during pregnancy, suggesting that the use of sdNVP monotherapy may have been high, which falls 
below the standard of care set out in the national PMTCT guidelines at the time of data collection. 
Conversely, failure to include PMTCT prophylaxis prescribed at the HIV clinic in the ANC and 
maternity records or in the monthly reports from these departments meant that a small number of
women who received PMTCT prophylaxis or HAART were reported as having received no 
intervention.
Nurses’ lack of attention to potential inaccuracies in the PMTCT data at facility-level and in reports 
to the district reflects their non-use of these data for day-to-day monitoring of clinic performance –
a situation previously described as a culture of reporting rather than information-use.[11] Improving 
nurses’ understanding of these data and their relevance to client management is critical to ensuring 
greater attention to data recording and reporting. Motivation might be improved by introducing 
reporting feedback loops at facility, district and national levels whereby performance is tracked over 
time and compared with other departments/facilities. 
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A combination of factors affects the quality of PMTCT data in Kenya, some relating to the data 
collection and reporting tools, and others relating to how health workers fulfil their reporting tasks. 
The reporting tools exclude women who knew their HIV-positive status prior to pregnancy and 
PMTCT prophylaxis provided at the HIV clinic from the coverage indicator, fail to distinguish between 
different PMTCT regimens provided, and promote double-counting. That the registers were filled in 
differently in the two study facilities attests to the insufficient clarity of instruction and supervision 
with regard to data collection and reporting at facility-level. As a result, district-level reports 
constitute aggregations of non-standardised data on the coverage of PMTCT services. Irrespective of 
how the registers were filled in it would have been impossible to accurately determine coverage of 
PMTCT services using the available tools. 
Moving forward, efforts are required to facilitate reporting that captures data on all HIV-positive 
women attending MCH services, divided into those who are newly-diagnosed and those of 
previously-known HIV status. This would allow for continued capture of new HIV diagnoses and also 
provide the denominator for coverage calculations. For the numerator for such calculations, it will 
be important to address the issues of double-counting inherent in the current system used in Gilgil
Hospital. Furthermore, either data on AZT and 3TC prescribed from the HIV clinic should be included 
in monthly reporting on PMTCT or, for pregnant and post-natal women, these drugs should be 
availed exclusively within ANC and maternity services. 
Following data collection for this study, a new ANC register has been developed by the government
that allows for separate recording of new HIV diagnoses and women already known to be HIV-
positive, as well as differentiation of the PMTCT regimen provided. When the related reporting 
forms are revised so that facilities can report this information to district and hence to national levels 
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this will assist in understanding coverage of PMTCT by drug regimen. However, it will not solve the 
bigger problem of multiple counting of the same woman. 
When introduced, if appropriately designed, a longitudinal ANC register and an electronic health 
information system throughout Kenya should substantially reduce the multiple counting of women 
who attend ANC more than once. The longitudinal ANC register will not solve the potential for 
double-counting among women attending both ANC and maternity but this might be helped by an 
electronic health information system that networks different departments within and across health 
facilities.
Such new health information tools need to be extensively pilot tested to ensure that they are 
sufficiently simple and well-explained to ensure accurate reporting by over-burdened health 
workers. Health workers will require unambiguous written instructions within the registers and 
forms themselves on how they should be completed and submitted. Staff mentorship on record-
keeping may well be needed, and continued supervision to ensure that all health facilities enter and 
compile the data correctly will be essential. WHO’s forthcoming publication on monitoring and 
evaluating national PMTCT programmes might help to inform these tools.[13]
CONCLUSION
Weaknesses in the reporting system and staff training/supervision on reporting have led to 
differences in reporting practices and inaccuracies in data on the provision of maternal PMTCT 
prophylaxis, primarily resulting in over-estimation of coverage in the two study health facilities. If 
replicated elsewhere, this could lead to an over-estimation of national PMTCT coverage. Routine 
data collection systems which are simple yet accurate are needed in order to monitor effective 
PMTCT coverage and to highlight where changes need to be made so as to ensure that infants are 
born HIV-free.
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KEY MESSAGES
- Weaknesses in the reporting system and staff training/supervision have led to inaccuracies 
in data on the provision of maternal PMTCT prophylaxis in Kenya.
- Routinely-collected data on maternal PMTCT prophylaxis provision led to substantial over-
estimation of coverage in the two study health facilities that may also occur elsewhere. 
- Accurate routine data collection systems are needed to monitor PMTCT coverage and 
highlight where changes are needed to ensure that infants are born HIV-free.
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